Device Trial Radar · NCT04192474
Evaluation of Performance and Safety of Ambu® aScope™ 4 Cysto and aView™ Urologia for Flexible Cystoscopy
Last checked: Nov 20, 2026Latest source record: Oct 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
83
Actual
Start
Jul 21, 2020
Primary completion
Apr 7, 2021
Study completion Jun 30, 2021
Sponsor
- Lead sponsor
- Ambu A/SNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- QserveCRO
- First posted
- Dec 10, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In this study, the new aScope 4 Cysto is used to see if this new single use, flexible cystoscope performs as well as other routinely used flexible cystoscopes. This study will be done in patients who come to the clinic for either a diagnosis of their urethra and bladder or for a small intervention. For an intervention a lesion or tumor is resected, a stent in the ureter is taken out, or an injection in the bladder wall is given. The flexible cystoscope is passed into the urethra and bladder for visual inspection of the bladder and urethra. It will give information on how well the structures of the urinary tract and bladder can be viewed including any abnormalities that are present. If an intervention is performed the aScope 4 Cysto will be used with an endoscopic accessory.
Conditions
- Cystoscope
- Lower Urinary Tract Symptoms
- Bladder Disease
Interventions
Flexible cystoscopyDevice
Treatment with the investigational device: Ambu® aScope™ 4 Cysto
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance of the cystoscopeTime frame: follow up immediately after procedure
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Herlev Hospital
Herlev, Denmark
Erasmus MC
Rotterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.